Skip to main content
Clinical Trials/NCT01134302
NCT01134302
Unknown
Phase 3

The Influence of Postoperative Systemic Oxygen Transport on Neurologic and Functional Outcomes in Infants Undergoing Single Ventricle Palliation With Norwood and Hybrid Management Strategies

The Hospital for Sick Children1 site in 1 country50 target enrollmentMarch 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Congenital Heart Disease
Sponsor
The Hospital for Sick Children
Enrollment
50
Locations
1
Primary Endpoint
Neurologic and functional outcomes
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this trial is to determine, at 3 years of life, how the neurologic and functional outcomes in infants with single ventricles are different when comparing children treated with the Hybrid strategy to the Norwood strategy.

Detailed Description

Neurologic deficits in children with single ventricle physiology are believed to be associated with the reconstruction of the aortic arch during the initial Norwood procedure as a neonate. In the last few years, a new management strategy (the 'Hybrid' strategy) has been proposed which defers the aortic arch reconstruction to a second stage procedure at 4-6 months of age. Proponents of the Hybrid strategy assert that the avoidance of cardiopulmonary bypass and circulatory arrest in the neonatal period will avoid neurologic injury in the critical neonatal period and thereby result in superior long-term neurologic outcomes. We are testing whether the Hybrid management strategy is associated with superior neurologic outcomes or not.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
March 2012
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of functional single ventricle anatomy amenable to Norwood or Hybrid first stage palliation.
  • Informed consent of parent(s) or legal guardian.

Exclusion Criteria

  • Pre-operative identification of anatomy rendering either a Norwood or Hybrid procedure clinically inappropriate;
  • Recent history of significant cerebral bleed or necrotizing enterocolitis;
  • Severe hemodynamic instability;
  • Any other major congenital abnormality (i.e. congenital diaphragmatic hernia, tracheoesophageal fistula) or clinically significant acquired extra-cardiac disorder (e.g. meconium aspiration with need for high frequency ventilation, persistent renal failure requiring dialysis).

Outcomes

Primary Outcomes

Neurologic and functional outcomes

Time Frame: 3 years of age (during procedure 3 pre-op)

At \~3 years of age, the Vineland Scale,the Mullen Developmental Scale, and the BASC behavioural scale will be formally assessed

Secondary Outcomes

  • Hemodynamic Assessment(Baseline and 4-6 months)
  • Blood Sampling(Baseline and 4-6 months)
  • Systemic Oxygen Consumption(Baseline and 4-6 months)
  • Cerebral Oxygen Transport Surrogate Measurements(Baseline and 4-6 months)
  • Cerebral Blood Flow Velocity(Baseline and 4-6 months)
  • Electroencephalograph(Baseline and 4-6 months)
  • MRI scans(Baseline, 4-6 months and 2-3 years)

Study Sites (1)

Loading locations...

Similar Trials